Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
Research News
Donate Now
Parkinson's Research

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.
  • Laboratory Beaker Glasses

    A Pill to Stop Parkinson's?

    Recent news is touting a potential pill to stop Parkinson's. MJFF-funded research is the basis of this story, but sometimes it can be hard to separate hope from hype.
    Learn more Save for later
  • Brain Commons Logo

    The Michael J. Fox Foundation Joins BRAIN Commons to Accelerate Brain Disease Research

    MJFF joins BRAIN Commons, a data sharing platform for data analyzes in PD, to help fuel collaborative science.
    Learn more Save for later
  • Scientist in Lab

    The Appendix and Parkinson's: 'It's a Piece to the Puzzle'

    Rachel Dolhun, MD, vice president of medical communication at the Foundation comments on these findings.
    Learn more Save for later
  • Neuroscience 2018 Logo

    MJFF Heads to Neuroscience 2018 Conference

    Staff and funded investigators from The Michael J. Fox Foundation will be presenting posters and symposia throughout the conference.
    Learn more Save for later
  • Fox Insight Logo

    One Year Later, Thousands Speed Research Using Fox Insight

    Fox Insight, the Foundation's online clinical study, empowers those with PD to share their lived experience with the disease to speed research.
    Learn more Save for later
  • MJFF CEO Todd Sherer and Carole Ho, MD, of Denali Therapeutics

    Five Highlights from Our Conference Illustrate Momentum in Parkinson's Research

    Presenters shared their latest findings in sessions focused on targets and biology, biomarkers and outcome measures and hot topics in the field.
    Learn more Save for later
  • Pfizer's Parkinson's Drugs Will Be Developed by Start-up Cerevel Therapeutics

    Pfizer's Parkinson's Drugs Will Be Developed by Start-up Cerevel Therapeutics

    Cerevel Therapeutics gains preclinical and clinical-stage drugs from Pfizer's previous neuroscience program.
    Learn more Save for later
Close-up portrait

Join the Study that's Changing Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
Todd Sherer, PhD
Todd Sherer, PhD Chief Mission Officer
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.